Tonsil mesenchymal stem cells-derived extracellular vesicles prevent submandibular gland dysfunction in ovariectomized rats

Dry mouth that occurs after menopause significantly reduces the quality of life of the elderly. The extracellular vesicles derived from mesenchymal stem cells are being studied for application in various pathological conditions in the field of tissue regenerative medicine. This study is to investigate the therapeutic effect on salivary gland dysfunction occurring after ovariectomy using tonsil mesenchymal stem cells (T-MSCs)-derived extracellular vesicles. The rats were divided into the following groups: sham-operated rats (SHAM), rats that underwent ovariectomy (OVX), and rats that underwent OVX surgery and were simultaneously injected with T-MSC-derived extracellular vesicles (OVX+EV). The rats were sacrificed 6 weeks after ovariectomy. Estradiol levels decreased in the OVX group compared with those in the SHAM group. Extracellular vesicles had no effect on estradiol levels or estrogen receptor beta expression. The evaluation of pro-inflammatory cytokines, TNF-alpha and IL-6, increased in the OVX group and decreased in the OVX+EV group. The expressions of collagen I and TGF beta I increased in the OVX group but decreased in the OVX+EV group. Moreover, to examine submandibular gland function, AQP5 and alpha-amylase expressions were downregulated in the OVX group, but improved upon exosome injection. In conclusion, T-MSC-derived extracellular vesicles are useful for the prevented submandibular gland dysfunction that occurs after menopause.

Automated summary

The study found that extracellular vesicles derived from T-MSCs are effective in treating salivary gland dysfunction occurring after menopause, reducing inflammatory cytokine expression and levels of collagen and TGF beta I.